Access to part 1 (Modules 1 to 4) of the Oncology Pharmacotherapy and Applications of Biosimilars (OPAB) Program is open!  

The program consists of 10 online modules (25 hours) and you can choose to take the accredited program, earning you a Certificate of Completion with 25 CEUs, or the non-accredited program, receiving a Letter of Participation with no CEUs awarded. 

The OPAB Program is complimentary for ISOPP members and geared towards oncology pharmacists who have practiced for at least one year in the area of oncology pharmacy.  

Note: You must be member of ISOPP in 2022 to be eligible for complimentary ISOPP offerings taking place in 2022, such as the Virtual Symposium and OPAB Program. Membership renewal for January 1, 2022 to December 31, 2022 opens shortly. Watch your inbox.   

If you haven’t already, be sure to register to receive access to the program and begin your training! Not a member? Join ISOPP now!   

Visit ISOPP's OPAB webpage for an overview of the program, its learning objectives, Faculty members and a disclaimer.  
 

We acknowledge the Faculty members, Reviewers and Task Force members for their contributions to the OPAB Program.

This program is supported by an educational grant from Pfizer.

Accreditation for this program is provided by the California Society of Health-System Pharmacists (CSHP). CSHP is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.